Soundtec Direct System
This article was originally published in The Gray Sheet
Executive Summary
Ear canal sound processor for the middle ear implantable hearing device gains FDA go-ahead. The magnet-based component can be implanted in less than 30 minutes in an outpatient procedure. The ear canal processor is intended to be cosmetically more pleasing than the behind-the-ear processor that was available when the Direct System gained PMA approval in September 2001 (1"The Gray Sheet" Oct. 1, 2001, p. 20)...
You may also be interested in...
Soundtec Direct System Priced To Offset Poor Reimbursement Environment
Soundtec will sell its Direct System implantable middle ear hearing device at a competitively low price in an effort to counterbalance the potential lack of reimbursement from third-party payers.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.